Cryptococcal meningoencephalitis in multiple sclerosis treated with fingolimod

Pract Neurol. 2023 Nov 23;23(6):512-515. doi: 10.1136/pn-2023-003691.

Abstract

A 21-year-old woman with multiple sclerosis (taking regular fingolimod) developed sudden-onset severe headache with nausea and malaise. Neurological examination was normal and she was afebrile. Blood results showed lymphocytes 0.53 x 109/L and C reactive protein 19 mg/L. CT scan of head and venogram were normal. CSF showed an opening pressure of 33 cm H2O and an incidental light growth of Cryptococcus neoformans, confirmed with positive India Ink stain and a positive cryptococcal antigen (1:100). She was treated for cryptococcal meningoencephalitis with amphotericin and flucytosine. Her presenting symptoms had closely mimicked subarachnoid haemorrhage. This atypical presentation of cryptococcal CNS infection highlights the need for vigilance in immunosuppressed patients.

Keywords: INFECTIOUS DISEASES; MICROBIOLOGY; SUBARACHNOID HAEMORRHAGE.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B
  • Female
  • Fingolimod Hydrochloride / adverse effects
  • Humans
  • Meningitis, Cryptococcal* / drug therapy
  • Meningoencephalitis* / drug therapy
  • Multiple Sclerosis*
  • Young Adult

Substances

  • Fingolimod Hydrochloride
  • Amphotericin B